.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Teva
Argus Health
Novartis
McKinsey
Cipla
Covington
AstraZeneca
Johnson and Johnson
Julphar

Generated: November 24, 2017

DrugPatentWatch Database Preview

Rifampin - Generic Drug Details

« Back to Dashboard

What are the generic sources for rifampin and what is the scope of rifampin freedom to operate?

Rifampin
is the generic ingredient in three branded drugs marketed by Emcure Pharms Ltd, Akorn, Sanofi Aventis Us, West-ward Pharms Int, Mylan Labs Ltd, Oxford Pharms, Lupin Pharms, Watson Pharms Teva, Hikma Pharms, Sandoz, Fresenius Kabi Usa, and Lannett, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for rifampin. Twenty-five suppliers are listed for this compound.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
RIFADIN
rifampin
INJECTABLE;INJECTION050627-001May 25, 1989APRXYesYes► Subscribe► Subscribe► Subscribe
Oxford Pharms
RIMACTANE
rifampin
CAPSULE;ORAL050429-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Pharms
RIFAMPIN
rifampin
CAPSULE;ORAL090034-001Aug 21, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Pharms Teva
RIFAMPIN
rifampin
INJECTABLE;INJECTION206736-001Jan 19, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
RIFADIN
rifampin
CAPSULE;ORAL062303-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
RIFAMPIN
rifampin
CAPSULE;ORAL064150-001May 28, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
RIFADIN
rifampin
CAPSULE;ORAL050420-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Lupin Pharms
RIFAMPIN
rifampin
CAPSULE;ORAL090034-002Aug 21, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Lannett
RIFAMPIN
rifampin
CAPSULE;ORAL065390-001Mar 28, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Akorn
RIFAMPIN
rifampin
CAPSULE;ORAL065028-002Mar 14, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Citi
QuintilesIMS
Harvard Business School
Colorcon
UBS
Boehringer Ingelheim
US Department of Justice
Farmers Insurance
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot